Hyperscale Data Reaffirms Guidance, Plans Q3 Call on ACG Divestiture

What happened

Hyperscale Data (GPUS) reaffirmed its 2026 revenue guidance of $180M-$200M on July 8, 2026, citing continued execution across its AI infrastructure, digital assets, and diversified businesses, while also announcing a Q3 stockholder conference call to discuss the planned divestiture of Ault Capital Group and long-term growth strategy. The company touted a recently announced Master Services Agreement valued at $1.2B to $3.0B as a catalyst for future revenue growth and improving cash flow. However, the master report highlights that the MSA requires a $100M-$120M retrofit of the Michigan facility, with Phase 1 (10MW) targeted for readiness by September 21, 2026, and that funding is heavily reliant on equity-linked capital that has already produced massive dilution—shares outstanding ballooned from 109M in November 2025 to 479M by June 2026. The company's Q1 2026 net loss of $30.1M and negative free cash flow underscore the precarious financial position, with near-term obligations and capex demands far exceeding available cash. Investors should view the reaffirmed guidance and MSA fanfare as a narrative push to maintain stock momentum while the underlying execution risk and dilutive financing pressures remain acute.

Implication

Hyperscale Data's reaffirmation of 2026 guidance provides no new operational proof—the $180M-$200M revenue figure was already disclosed and relies on the successful conversion of the Michigan facility from Bitcoin mining to AI colocation. The stock's recent trading at ~$0.17 reflects extreme dilution (shares outstanding up 340% in seven months) and implies the market is skeptical that the MSA's headline $1.2B-$3.0B potential will translate into per-share value given the $100M-$120M retrofit capex requirement. Investors should require concrete evidence of Phase 1 readiness by September 21, 2026—the first contractual milestone—and a visible slowdown in ATM or Yorkville drawdowns. Without these, further capital raises will likely pressure the stock, while any delay in the timeline would validate the bear case of a dilution-funded option. The Q3 call on the ACG divestiture may distract but does not change the fundamental dependency on timely commissioning. Until then, the risk-reward is unattractive, with the implied base case price of $0.22 offering little upside from current levels and a bear case of $0.12 representing significant downside.

Thesis delta

No material shift in thesis. The reaffirmed guidance and MSA promotion are consistent with management's existing narrative but provide no incremental evidence of execution against the critical September 21, 2026 Phase 1 milestone or a reduction in dilutive financing. The risk-reward remains asymmetrically negative, with the stock priced for a successful delivery that is still unproven and funded by an equity structure that systematically undermines per-share value.